Parallel trade ban on 30 drugs to stop Brexit profiteering
Ministers are to ban the export of up to 30 drugs to prevent wholesaler profiteering in the run-up to a no-deal Brexit, The Times has reported.
The paper said today that due to concerns around parallel trade if the pound suffers ahead of a no-deal Brexit, the Government plans to implement a temporary export ban that will apply to critically important drugs that are thought to be vulnerable to shortages, including HRT and epilepsy drugs.
The ban, which will apply to wholesalers and not manufacturers, is to take immediate effect this week.
A source told The Times: “It’s a free market and if companies can get more for their drugs on the Continent then they’re going to do that and it will be too late for the government to stop them. If the pound devalues by 10 per cent then there is a clear financial incentive for the wholesalers not to sell in the UK.”
The ban is thought to focus mainly on the lead time before a no-Brexit period rather than the aftermath, as European wholesalers will not be able to import drugs from Britain in the same way if the UK leaves without a deal.
The pharmaceutical industry has created a six-week stockpile of most vital medicines to help ensure uninterrupted supply in case of a no-deal Brexit. However, the Times reports of industry fears “that these stockpiles could be depleted by wholesalers exporting more medicines if a weaker pound means higher prices elsewhere in Europe”.
The Association of the British Pharmaceutical Industry, which has been calling for such a ban for several months, told the paper: “In the run-up to a no-deal Brexit there could be currency fluctuation and some fall in the value of the pound.
“You can imagine in that situation that exporting medicines into Europe would become even more profitable. It may be that drugs that currently aren’t being exported suddenly become attractive to export, driven entirely by profit.”
A representative of the UK's larger wholesalers appeared to partly blame smaller companies for the threat of no-deal profiteering, with Healthcare Distribution Association chief Martin Sawer telling The Times: “We do have concerns that some smaller export businesses are creating pressure on some of our members for a product… we have to think about whether businesses are using something for dispensing or are they going to speculate.”
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Home-use antibody tests could be approved 'within months'
A coronavirus antibody test is currently undergoing ‘ease of use trials’ to determine whether it can be used by the general public.
2 Min Article
Sign up for CPCS, urges NHS England integration chief
NHSE wants as many contractors as possible signed up to the service by October 29.
3 Min Article
BAME risk assessments ‘must be carried out within weeks’
Employers must carry out Covid-19 risk assessments for all staff in at-risk groups within the next few weeks, NHS England & Improvement has said.
3 Min Article
Duchess of Cornwall praises pharmacy teams in Sussex visit
The Duchess of Cornwall met with community pharmacy workers yesterday to learn about the role they have played during the Covid-19 pandemic.
2 Min Article
Helping customers treat & care for their scalp
Understanding the causes and symptoms of some common scalp conditions will help you to make a real difference to your customers’ lives. Complete this module to discover self-care and product advice to help ease symptoms and maintain scalp health.
24 Min Module
Relief from the nasal symptoms of allergy
With NHS England advising that OTC products should no longer be prescribed to treat mild-to-moderate hayfever, pharmacy’s role in supporting sufferers is more important than ever. This module includes self-care advice and product recommendations to aid customer conversations.
15 Min Module